Efficacy and safety of Dengyinnaotong Capsule in patients with Cognitive impairment caused by cerebral Small Vessel Disease: study protocol of a multicenter, randomized, open-label, controlled trial (De-CSVD trial)

BACKGROUND: Cerebral small vessel disease (CSVD) is a common syndrome in the older population, with a prevalence ranging from 5% in subjects aged 50 years to almost 100% in those aged 90 years and older. It is regarded to be a major cause of vascular cognitive impairment. Existing prevention and tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yan-Xia, Li, Jin-Cun, Tian, Min, Zheng, Mao-Yong, Zhang, Li-Ping, Zhang, Jin-Lu, Yu, Feng, Li, Yi-Zhao, Zhang, Qing-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386924/
https://www.ncbi.nlm.nih.gov/pubmed/35978350
http://dx.doi.org/10.1186/s13063-022-06646-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386924/
https://www.ncbi.nlm.nih.gov/pubmed/35978350
http://dx.doi.org/10.1186/s13063-022-06646-6

Ejemplares similares